Your browser doesn't support javascript.
loading
Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
Derosa, G; Maffioli, P; Ferrari, I; Mereu, R; Ragonesi, P D; Querci, F; Franzetti, I G; Gadaleta, G; Ciccarelli, L; Piccinni, M N; D'Angelo, A; Salvadeo, S A T.
Affiliation
  • Derosa G; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuseppe.derosa@unipv.it
Horm Metab Res ; 42(9): 663-9, 2010 Aug.
Article in En | MEDLINE | ID: mdl-20560108

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Sulfonylurea Compounds / Adamantane / Thiazolidinediones / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Nitriles Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Horm Metab Res Year: 2010 Document type: Article Affiliation country: Italy Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Sulfonylurea Compounds / Adamantane / Thiazolidinediones / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Nitriles Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Horm Metab Res Year: 2010 Document type: Article Affiliation country: Italy Country of publication: Germany